Topotecan

Product manufactured by Hospira, Inc.

Application Nr Approved Date Route Status External Links
NDA200582 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Topotecan Injection Is Indicated For The Treatment Of Patients With Small Cell Lung Cancer (Sclc) With Platinum-Sensitive Disease Who Progressed At Least 60 Days After Initiation Of First-Line Chemotherapy. Topotecan Injection Is A Topoisomerase Inhibitor Indicated For Treatment Of Small Cell Lung Cancer (Sclc) Platinum-Sensitive Disease In Patients Who Progressed At Least 60 Days After Initiation Of First-Line Chemotherapy. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Topotecan Hydrochloride TOPOTECAN HYDROCHLORIDE ZINC1611274

Comments